Loading…
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A Children's Oncology Group phase II study
Background The prognosis for children with brain stem glioma remains grim. Based on studies suggesting efficacy of vincristine and oral VP‐16, The Pediatric Oncology Group (POG, now part of the Children's Oncology Group) conducted a study using these agents in combination with standard external...
Saved in:
Published in: | Pediatric Blood & Cancer 2008-02, Vol.50 (2), p.227-230 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
The prognosis for children with brain stem glioma remains grim. Based on studies suggesting efficacy of vincristine and oral VP‐16, The Pediatric Oncology Group (POG, now part of the Children's Oncology Group) conducted a study using these agents in combination with standard external beam radiation for children with newly diagnosed brain stem glioma.
Methods
Children were eligible for the study if they 3–21 years of age, had MRI‐evidence of a diffuse intrinsic pontine glioma, and had neurologic deficits of |
---|---|
ISSN: | 1545-5009 1545-5017 1096-911X |
DOI: | 10.1002/pbc.21154 |